Tevogen Bio Holdings Stock EBITDA
| TVGNW Stock | 0.06 0 5.66% |
Tevogen Bio Holdings fundamentals help investors to digest information that contributes to Tevogen Bio's financial success or failures. It also enables traders to predict the movement of Tevogen Stock. The fundamental analysis module provides a way to measure Tevogen Bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Tevogen Bio stock.
| Last Reported | Projected for Next Year | ||
| EBITDA | 188.7 K | 198.1 K |
Tevogen |
Tevogen Bio Holdings Company EBITDA Analysis
Tevogen Bio's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Tevogen Bio EBITDA | 188.71 K |
Most of Tevogen Bio's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Tevogen Bio Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Tevogen EBITDA Driver Correlations
Understanding the fundamental principles of building solid financial models for Tevogen Bio is extremely important. It helps to project a fair market value of Tevogen Stock properly, considering its historical fundamentals such as EBITDA. Since Tevogen Bio's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Tevogen Bio's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Tevogen Bio's interrelated accounts and indicators.
Click cells to compare fundamentals
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
Tevogen Ebitda
Ebitda |
|
According to the company disclosure, Tevogen Bio Holdings reported earnings before interest,tax, depreciation and amortization of 188.71 K. This is 99.98% lower than that of the Healthcare sector and 99.81% lower than that of the Biotechnology industry. The ebitda for all United States stocks is 100.0% higher than that of the company.
Tevogen EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Tevogen Bio's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Tevogen Bio could also be used in its relative valuation, which is a method of valuing Tevogen Bio by comparing valuation metrics of similar companies.Tevogen Bio is currently under evaluation in ebitda category among its peers.
Tevogen Fundamentals
| EBITDA | 188.71 K | ||||
| Net Income | (67.33 K) | ||||
| Total Debt | 1.63 M | ||||
| Cash Flow From Operations | (1.38 M) | ||||
| Total Asset | 17.04 M | ||||
| Retained Earnings | (17.38 M) | ||||
| Working Capital | (2.65 M) | ||||
| Net Asset | 17.04 M |
About Tevogen Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Tevogen Bio Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Tevogen Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Tevogen Bio Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Tevogen Stock Analysis
When running Tevogen Bio's price analysis, check to measure Tevogen Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tevogen Bio is operating at the current time. Most of Tevogen Bio's value examination focuses on studying past and present price action to predict the probability of Tevogen Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tevogen Bio's price. Additionally, you may evaluate how the addition of Tevogen Bio to your portfolios can decrease your overall portfolio volatility.